Union health ministry has issued a revised guidelines, recommending the EUA/off-label use of Tocilizumab drug in case of severe diseases, preferably within 24 to 48 hours of the onset of the disease
from Latest News https://ift.tt/2QtFlbP
Thursday, 22 April 2021
Govt issues revised clinical guidance for management of Covid-19 patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment